IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 84 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $32,000 | – | 24,771 | +50453.1% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 49 | -98.9% | 0.00% | – |
| Q4 2016 | $6,000 | -96.7% | 4,389 | -93.9% | 0.00% | -100.0% |
| Q3 2016 | $184,000 | +868.4% | 71,935 | +1068.3% | 0.01% | +1100.0% |
| Q4 2015 | $19,000 | +1800.0% | 6,157 | +1325.2% | 0.00% | – |
| Q3 2015 | $1,000 | -96.6% | 432 | -94.6% | 0.00% | -100.0% |
| Q2 2015 | $29,000 | +26.1% | 8,056 | +25.5% | 0.00% | -33.3% |
| Q1 2015 | $23,000 | – | 6,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,550,000 | $16,437,000 | 2.17% |
| Ghost Tree Capital, LLC | 550,000 | $2,547,000 | 1.57% |
| HealthCor Management, L.P. | 3,350,000 | $15,511,000 | 0.94% |
| EAM Investors, LLC | 541,969 | $2,509,000 | 0.45% |
| Baker Brothers Advisors | 3,171,765 | $14,685,000 | 0.21% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 405,729 | $1,878,000 | 0.16% |
| Spark Investment Management LLC | 169,000 | $779,000 | 0.14% |
| CARL DOMINO INC | 50,137 | $232,000 | 0.13% |
| NATIXIS | 3,149,816 | $14,583,000 | 0.12% |
| HOLLENCREST CAPITAL MANAGEMENT | 132,000 | $611,000 | 0.10% |